Eli Lilly Stock Analysis: Still a Buy After 58% YTD Gain?

Aug 19, 2024 · Eli Lilly & Co. (NYSE:LLY) has been a standout performer in the pharmaceutical industry, with its stock surging 58% year-to-date (YTD) and an impressive 68.6% over the past …

CouponFollow Extension

58%
OFF

Eli Lilly Stock Analysis: Still A Buy After 58% YTD Gain?

3 weeks from now

Aug 19, 2024 · Eli Lilly & Co. (NYSE:LLY) has been a standout performer in the pharmaceutical industry, with its stock surging 58% year-to-date (YTD) and an impressive 68.6% over the past …

upalpha.com

58%
OFF

Up 58% YTD, Is Eli Lilly Stock Still A Buy? - Nasdaq

3 weeks from now

Aug 19, 2024 · Up 58% YTD, is Eli Lilly Stock Still a Buy? August 19, 2024 — 03:14 pm EDT. ... The Street-high price target of $1,117 suggests that Eli Lilly stock could rise as much as …

nasdaq.com

58%
OFF

Up 58% YTD, Is Eli Lilly Stock Still A Buy? - Barchart.com

3 weeks from now

Stock Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & …

barchart.com

5%
OFF

Is Eli Lilly Stock Still A Buy Near All-Time Highs? - Nasdaq

3 weeks from now

Eli Lilly stock is trading near its all-time highs, with the shares only about 5% away from the record levels set in August. With the shares up nearly 68% in the past 52 weeks and 58.5% year-to ...

nasdaq.com

20%
OFF

Eli Lilly Just Hit A Milestone That Disappointed. Here's Why You …

3 weeks from now

Nov 8, 2024 · During Q3, Eli Lilly brought in $11.4 billion in sales, up 20% from a year prior, and non-GAAP (adjusted) EPS of $1.18, which was $0.29 less than what the average of Wall …

fool.com

58%
OFF

Up 58% YTD, Is Eli Lilly Stock Still A Buy? - TradingView

3 weeks from now

Aug 19, 2024 · The Street-high price target of $1,117 suggests that Eli Lilly stock could rise as much as 21.4% from here. At nearly 58x forward adjusted earnings, LLY stock is definitely …

tradingview.com

39%
OFF

Should You Buy The Dip In Eli Lilly Stock Right Now?

3 weeks from now

Jan 19, 2025 · 2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (LLY-0.39%).At one point, share prices had gained as much as 65% on the year. However, after a …

fool.com

58%
OFF

Up 58% YTD, Is Eli Lilly Stock Still A Buy? - The Globe And Mail

3 weeks from now

Aug 19, 2024 · The Street-high price target of $1,117 suggests that Eli Lilly stock could rise as much as 21.4% from here. At nearly 58x forward adjusted earnings, LLY stock is definitely …

theglobeandmail.com

5%
OFF

Eli Lilly And Company (LLY) Stock Price, Quote & News - Stock …

3 weeks from now

3 days ago · Eli Lilly cuts Q4 sales forecast, but analyst remains bullish on stock—here's why. Eli Lilly (LLY) reduced its fourth-quarter sales guidance by 5%, lowering expectations to $13.5 …

stockanalysis.com

7%
OFF

Eli Lilly Stock: Why There's Still A Lot To Like In 2025 Despite ...

3 weeks from now

Jan 15, 2025 · That followed a 7% dive on Tuesday after Eli Lilly updated its guidance. The company also said it expects 2025 sales to be in the range of $58 billion to $61 billion, up 32% …

investors.com

39%
OFF

Has Eli Lilly Stock Peaked? - The Motley Fool

3 weeks from now

Jan 15, 2025 · Eli Lilly (LLY-0.39%) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like it might be on track to be …

fool.com

$45
OFF

Eli Lilly Stock Update: What Investors Should Watch In 2025

3 weeks from now

6 days ago · Investors might keep in mind that Eli Lilly still projects substantial top-line growth for 2024 and especially for 2025. The company expects $45 billion in revenue for 2024 and …

marketbeat.com

40%
OFF

Eli Lilly Stock's Correction Brings Opportunity (NYSE:LLY)

3 weeks from now

2 days ago · Occupying over 40% of a fast-growing weight loss drug market, Eli Lilly and Company (NYSE:LLY) stock has been growing at a CAGR of over 30% since 2015 to its ATH …

seekingalpha.com

FAQs about Eli Lilly Stock Analysis: Still a Buy After 58% YTD Gain? Coupon?

Is Eli Lilly stock a buy?

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation. ...

Should you buy Eli Lilly (ell) now?

Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock. Eli Lilly's latest earnings report was not interpreted positively by the market. Its bestselling drugs reaching a point where supply is meeting demand was the issue. There is still a lot of upcoming growth priced into this stock's valuation. ...

Is Eli Lilly stock hitting new all-time highs?

Eli Lilly's stock is hitting new all-time highs as earnings continue to grow at a rapid rate. Read more about LLY stock here. ...

Why did Eli Lilly stock fall 6%?

Eli Lilly stock (NYSE: LLY) fell over 6% on Tuesday, January 14, after it announced that the sales of its obesity drugs are seeing slower than anticipated growth. It has adjusted its Q4 revenue foreca... ...

Should you buy Eli Lilly & Company (LLY) in September 2024?

We previously covered Eli Lilly and Company (NYSE:NYSE: LLY) in September 2024, discussing why we had upgraded the stock as a Buy then, attributed to its secure long-term growth prospects from the improved supply in H2'24 and the incoming capacity additions from H1'25 onwards. ...

Is Eli Lilly's stock overvalued?

Source: Morningstar Direct. Data as of August 14, 2024. With its 2-star rating, we believe Eli Lilly’s stock is overvalued compared with our long-term fair value estimate of $540. Our assumptions for overall biopharma GLP-1 sales in 2031 are close to $170 billion across diabetes ($50 billion), obesity ($85 billion), and overweight ($35 billion). ...